Novozymes A/S (NVZMY) Receives New Coverage from Analysts at Berenberg Bank

Berenberg Bank initiated coverage on shares of Novozymes A/S (OTCMKTS:NVZMY) in a report released on Tuesday morning, reports. The firm issued a sell rating on the stock.

Novozymes A/S (OTCMKTS:NVZMY) opened at 43.185 on Tuesday. The company has a market cap of $12.97 billion, a PE ratio of 30.220 and a beta of 0.70. Novozymes A/S has a 52-week low of $37.98 and a 52-week high of $49.55. The firm’s 50-day moving average is $43.67 and its 200-day moving average is $46.08.

About Novozymes A/S

Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. In June 2013, the Company restructured its sales areas within those segments. The Household Care (old Household Care Enzymes) area comprises cleaning solutions, laundry, dishwashing and microorganism sales for cleaning solutions.

Stock Target Prices

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with's FREE daily email newsletter.

Leave a Reply

© 2006-2016 Mideast Time.